Do allergic diseases and ongoing allergen exposure cause elevated peripheral blood eosinophil counts?

Clinical evidence

• Established Etiology: Allergic diseases—including allergic asthma, allergic rhinitis, and atopic dermatitis—are the most common causes of mild-to-moderate peripheral blood eosinophilia in clinical practice.
• Prevalence & Diagnostics: Clinical cohorts demonstrate that approximately 40% to 60% of patients with allergic rhinitis exhibit an elevated absolute eosinophil count (AEC). Outpatient clinical evaluations consistently demonstrate that the vast majority of cases of unexplained mild-to-moderate peripheral eosinophilia (typically between 300 and 1,500 cells/µL) are ultimately attributed to underlying atopic or allergic conditions.

Mechanistic explanations

• The IL-5 Pathway: Ongoing allergen exposure activates tissue-resident Th2 cells and group 2 innate lymphoid cells (ILC2s), triggering the release of key type 2 cytokines, most notably interleukin-5 (IL-5), alongside IL-4 and IL-13.
• Bone Marrow Stimulation: IL-5 acts as the principal survival and hematopoietic growth factor for eosinophils. It binds to the IL-5 receptor alpha (IL-5Rα) on hematopoietic progenitor cells in the bone marrow, driving lineage commitment, differentiation, and accelerated maturation.
• Egress and Mobilization: Coordinated signaling by IL-5 and lipid mediators (such as 5-lipoxygenase-derived leukotrienes) facilitates the rapid egress of mature eosinophils from the bone marrow into the peripheral bloodstream.
• Temporal Dynamics: Persistent allergen exposure sustains this inflammatory cascade, establishing a chronic type 2 signaling niche that maintains elevated peripheral counts. Conversely, avoiding the allergen or removing the exposure halts this drive, leading to a subsequent decline in circulating eosinophils.

Bottom line

Allergic diseases and ongoing allergen exposure are highly common, scientifically validated causes of elevated peripheral blood eosinophil counts. This phenomenon is driven by a classic type 2 immune response wherein sustained allergen exposure stimulates Th2 cells and ILC2s to produce IL-5, which in turn accelerates bone marrow eosinophil production and mobilization into the circulation.